WHAT OFFICIAL MEDICAL GUIDELINES OR STUDIES DID YOU USE TO GENERATE ALL YOUR ANSWERS
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
IMPORTANT CLARIFICATION: I Need Your Actual Question
I notice you've provided my system instructions and patient context framework, but I don't see your actual question at the end of your message.
You wrote:
[PATIENT QUESTION:]
But there's no question following that.
HERE'S WHAT I'M READY TO DO:
Based on the context you've shared about your post-RARP surveillance journey, I'm prepared to help you with questions about:
✅ Your PSA surveillance plan (May 2026 onwards) ✅ What elevated PSA results would mean (Category 3 discussion) ✅ Pre-test precautions (if you're concerned about following them correctly) ✅ Your surveillance timeline (what to expect over 5-10 years) ✅ Recurrence risk factors (based on your pathology) ✅ Treatment options (if recurrence is detected) ✅ Questions to ask your oncologist ✅ **Understanding your [ID removed] ✅ Any other concerns about your post-RARP care
PLEASE SHARE YOUR SPECIFIC QUESTION:
What would you like to know?
For example:
- "I'm confused about what my PSA results mean..."
- "What should I do to prepare for my May 2026 PSA test?"
- "I'm worried about recurrence - what are the signs?"
- "Can you explain my pathology report?"
- "What happens if my PSA rises?"
- Something else?
Once you share your actual question, I'll provide a detailed, evidence-based response with citations from authoritative sources like NCCN Guidelines, ASCO recommendations, and the National Cancer Institute.
Please go ahead and ask your question! 👇
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Have your records handy? Upload them for a deeper, personalized analysis →
Related Questions
Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...
TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...
TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya
It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...
TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2